Novostia, a leading medical technology company advancing a groundbreaking heart valve replacement, has announced a leadership change and secured CHF 5.6 million in funding. Soad El Ghazouani has been appointed…
ImmunoPrecise Antibodies Ltd (IPA) (NASDAQ: IPA), a biotherapeutics research and technology company utilizing artificial intelligence, has reported its financial results for the first quarter of fiscal 2025, ending July 31,…
CVS Health® (NYSE: CVS) has announced that CVS Pharmacy® locations in Massachusetts are now offering hormonal contraceptive prescribing services. Patients seeking birth control can be evaluated by a CVS pharmacist…
CareDx, Inc. (Nasdaq: CDNA), a leader in precision medicine for transplant patients, announced today that it granted restricted stock units (RSUs) totaling 44,000 shares to 14 new employees on September…
CDR-Life has announced key advancements in its M-gager® programs targeting solid tumors, highlighting notable progress in its mission to develop innovative antibody fragment-based immunotherapies for challenging cancers. First Patient Dosed…
Tivic Health® Systems, Inc. (Nasdaq: TIVC), a leader in bioelectronic medicine, has appointed Lisa Wolf as its Interim Chief Financial Officer (CFO), effective October 1, 2024. Wolf succeeds Kimberly Bambach,…
Advanced eClinical Training (ACT), a top provider of online career certification, has joined forces with the SEIU-UHW West & Joint Employer Education Fund (The Education Fund), which offers employer-funded education,…
Neuraptive Therapeutics, Inc. has announced that its therapy NTX-001 has received Breakthrough Therapy Designation from the FDA, which could accelerate its development for patients with peripheral nerve injuries that need…
ŌURA, the company behind the Oura Ring, has announced its acquisition of Veri, a Finnish firm specializing in personalized metabolic health. Veri, which partners with Oura to offer metabolic insights…
Signet Healthcare Partners (“Signet”) has announced the successful sale of its portfolio company, Paragonix Technologies (“Paragonix”), to global medical technology leader Getinge. Paragonix, renowned for its advancements in organ transplantation…
CEL-SCI Corporation (NYSE American: CVM) announced that it will present new data from its Phase 3 study of Multikine (Leukocyte Interleukin Injection) at the European Society for Medical Oncology (ESMO)…
Cellino Biotech, Inc. announced today that it has been awarded up to $25 million by the Advanced Research Projects Agency for Health (ARPA-H), a division of the U.S. Department of…